Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Krawczyk

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
Pain Medicine (Malden, Mass.)|June 29, 2025
Opioid Dose, Duration, and Risk of Use Disorder in Medicaid Patients With Musculoskeletal PainAllison Perry, Noa Krawczyk, Hillary Samples, et al.
Drug and Alcohol Dependence|June 18, 2019
A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patientsHsien-Yen Chang, Noa Krawczyk, Kristin E Schneider, et al.
The International Journal on Drug Policy|August 4, 2023
Typology of laws restricting access to methadone treatment in the United States: A latent class analysisAnna Conway, Noa Krawczyk, Frances McGaffey, et al.
Journal of Addiction Medicine|June 2, 2023
Sensitivity of Medicaid Claims Data for Identifying Opioid Use Disorder in Patients Admitted to 6 New York City Public HospitalsJennifer McNeely, Shane D Gallagher, Medha Mazumdar, et al.
Addiction (Abingdon, England)|February 27, 2025
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onsetIgnacio Bórquez, Arthur R Williams, Mei-Chen Hu, et al.
Substance Use & Misuse|September 30, 2025
A Qualitative Study on the Impact of COVID-19 on Overdose Risk from the Perspective of Survivors and Witnesses of Drug Overdose: Lessons for Future Public Health EmergenciesHridika Shah, Sara Whaley, Isha K Desai, et al.
Preventive Medicine|May 5, 2023
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York CityBennett Allen, Cale Basaraba, Thomas Corbeil, et al.
Medical Care|September 14, 2020
The Impact of Various Risk Assessment Time Frames on the Performance of Opioid Overdose Forecasting ModelsHsien-Yen Chang, Lindsey Ferris, Matthew Eisenberg, et al.
Epidemiology (Cambridge, Mass.)|February 19, 2024
Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York CountiesMagdalena Cerdá, Ava D Hamilton, Ayaz Hyder, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Plos One|November 23, 2020
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)Thomas D Filardo, Maria R Khan, Noa Krawczyk, et al.
Pain Medicine (Malden, Mass.)|June 29, 2025
Opioid Dose, Duration, and Risk of Use Disorder in Medicaid Patients With Musculoskeletal PainAllison Perry, Noa Krawczyk, Hillary Samples, et al.
Drug and Alcohol Dependence|June 18, 2019
A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patientsHsien-Yen Chang, Noa Krawczyk, Kristin E Schneider, et al.
The International Journal on Drug Policy|August 4, 2023
Typology of laws restricting access to methadone treatment in the United States: A latent class analysisAnna Conway, Noa Krawczyk, Frances McGaffey, et al.
Journal of Addiction Medicine|June 2, 2023
Sensitivity of Medicaid Claims Data for Identifying Opioid Use Disorder in Patients Admitted to 6 New York City Public HospitalsJennifer McNeely, Shane D Gallagher, Medha Mazumdar, et al.
Addiction (Abingdon, England)|February 27, 2025
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onsetIgnacio Bórquez, Arthur R Williams, Mei-Chen Hu, et al.
Substance Use & Misuse|September 30, 2025
A Qualitative Study on the Impact of COVID-19 on Overdose Risk from the Perspective of Survivors and Witnesses of Drug Overdose: Lessons for Future Public Health EmergenciesHridika Shah, Sara Whaley, Isha K Desai, et al.
Preventive Medicine|May 5, 2023
Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York CityBennett Allen, Cale Basaraba, Thomas Corbeil, et al.
Medical Care|September 14, 2020
The Impact of Various Risk Assessment Time Frames on the Performance of Opioid Overdose Forecasting ModelsHsien-Yen Chang, Lindsey Ferris, Matthew Eisenberg, et al.
Epidemiology (Cambridge, Mass.)|February 19, 2024
Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York CountiesMagdalena Cerdá, Ava D Hamilton, Ayaz Hyder, et al.
Pageof 14